Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
3.060
0.00 (0.00%)
At close: Jun 18, 2026, 4:00 PM EDT
3.010
-0.050 (-1.63%)
Pre-market: Jun 22, 2026, 7:05 AM EDT
Biodexa Pharmaceuticals Market Cap
Biodexa Pharmaceuticals has a market cap or net worth of $2.28 million as of June 22, 2026. Its market cap has decreased by -31.91% in one year.
Market Cap
2.28M
Enterprise Value
-9.12M
1-Year Change
-31.91%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since February 26, 2019, Biodexa Pharmaceuticals's market cap has decreased from $102.08M to $2.28M, a decrease of -97.76%. That is a compound annual growth rate of -40.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.28M | 19.91% |
| Dec 31, 2025 | 1.90M | -19.05% |
| Dec 31, 2024 | 2.35M | -66.48% |
| Dec 29, 2023 | 7.02M | 78.13% |
| Dec 30, 2022 | 3.94M | -68.73% |
| Dec 31, 2021 | 12.60M | -43.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Onconetix | 3.48M |
| Virax Biolabs Group | 3.45M |
| Decoy Therapeutics | 3.23M |
| VivoSim Labs | 3.18M |
| Azitra | 2.78M |
| GRI Bio | 2.72M |
| Bone Biologics | 2.62M |
| Calidi Biotherapeutics | 2.60M |